Hualan Vaccine: Net profit of 183 million yuan in 2025, down 10.99% year-on-year

2026-04-07 08:49:40

Hualan Vaccine announcement: 2025 operating revenue was 1.203 billion yuan, up 6.62% year over year. Net profit was 183 million yuan, down 10.99% year over year. The profit distribution proposal deliberated and approved by the company’s board of directors is as follows: using 595 million as the basis, distribute a cash dividend of 8 yuan for every 10 shares to all shareholders (including tax), issue 0 bonus shares for every 10 shares to all shareholders (including tax), and increase share capital by converting 0 shares for every 10 shares to all shareholders from capital reserve funds.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes